Elevated breast cancer serum markers in otherwise healthy women

  • Authors:
    • O Merimsky
    • M Hareuveni
    • V Barak
    • F Sperber
    • Z Eshkol
    • S Chaitchik
  • View Affiliations

  • Published online on: July 1, 1997     https://doi.org/10.3892/or.4.4.829
  • Pages: 829-832
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

A high value of mucin-like carcinoma associated antigen (MCA), CA-15.3 or H23, in a woman known to have a diagnosis of breast cancer, may reflect presence of disease. A low level in a breast cancer patient may be accepted for remission, but a false negative result cannot be excluded. On the other hand, a low level of serum tumor marker in the general population actually lacks any significance. However, what is the meaning of an elevated level of marker, known to have a relatively high sensitivity and specificity, in an otherwise healthy woman? Does it mean an occult breast cancer or a false positive? Sera samples were obtained from 155 consecutive, otherwise healthy women, who were referred for mammography, and assayed for tumor markers. MCA was elevated in 15-24% of patients with normal mammogram, depending on their ages. Lack of elevation of a second marker in most of the cases supported the assumption that the elevation of the MCA was insignificant. Elevation of H23 occurred more frequently in younger women than in the elders, but was not associated with elevation of a second marker. In the cases with abnormal mammogram due to histologically proven benign disorders, serum tumor markers were generally within the normal ranges. Our results pointed to the lack of diagnostic significance of an elevated level of serum tumor marker, as far as the mammogram was normal or benign, there was no history of cancer nor any other systemic disease (including malignancy), and a second tumor marker was within the normal range. The women with presently false positive marker level may, however, be followed, because of the possible risk for future development of breast cancer.

Related Articles

Journal Cover

July 1997
Volume 4 Issue 4

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Merimsky O, Hareuveni M, Barak V, Sperber F, Eshkol Z and Chaitchik S: Elevated breast cancer serum markers in otherwise healthy women. Oncol Rep 4: 829-832, 1997
APA
Merimsky, O., Hareuveni, M., Barak, V., Sperber, F., Eshkol, Z., & Chaitchik, S. (1997). Elevated breast cancer serum markers in otherwise healthy women. Oncology Reports, 4, 829-832. https://doi.org/10.3892/or.4.4.829
MLA
Merimsky, O., Hareuveni, M., Barak, V., Sperber, F., Eshkol, Z., Chaitchik, S."Elevated breast cancer serum markers in otherwise healthy women". Oncology Reports 4.4 (1997): 829-832.
Chicago
Merimsky, O., Hareuveni, M., Barak, V., Sperber, F., Eshkol, Z., Chaitchik, S."Elevated breast cancer serum markers in otherwise healthy women". Oncology Reports 4, no. 4 (1997): 829-832. https://doi.org/10.3892/or.4.4.829